$2.14
+0.05 (+2.39%)
Open$2.15
Previous Close$2.09
Day High$2.20
Day Low$2.02
52W High$44.36
52W Low$19.01
Volume—
Avg Volume303.4K
Market Cap258.66M
P/E Ratio54.75
EPS$0.60
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+1,591.6% upside
Current
$2.14
$2.14
Target
$36.20
$36.20
$24.75
$36.20 avg
$54.95
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 50.41M | 45.49M | 44.34M |
| Net Income | -12,744,166 | -11,017,037 | -10,122,519 |
| Profit Margin | -25.3% | -24.2% | -22.8% |
| EBITDA | -16,231,640 | -13,211,435 | -14,610,213 |
| Free Cash Flow | -10,845,649 | -11,236,120 | -8,740,023 |
| Rev Growth | -0.9% | +9.2% | +11.8% |
| Debt/Equity | 0.67 | 0.72 | 0.74 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |